단계 미표기완료
Observational Study to Evaluate the Real-Life Effectiveness of Benepali Following Transition From Enbrel
연구 개요
The primary objective is to evaluate the effectiveness of Benepali in participants with Rheumatoid Arthritis (RA) and axial spondyloarthritis (axSpA), including participants with Ankylosing Spondylitis (AS) and non-radiographic axSpA, following their transition from treatment with Enbrel. The secondary objectives of this study are to describe clinical characteristics of patients transitioned from Enbrel® to Benepali® in routine practice, to evaluate safety during and following the transition from Enbrel to Benepali and to evaluate patient-reported outcomes during and following the transition from Enbrel to Benepali.
- 스폰서
- 협력: 삼성바이오에피스
- 적응증
- Rheumatoid Arthritis, Axial Spondyloarthritis
- 중재
- Benepali, Enbrel
- 목표 등록
- 585명
- 시작일
- 2017-06-01
- 완료(예정)
- 2018-11-30
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.